The Patent Finder

Yeast Cells Having Reductive TCA Pathway from Pyruvate to Succinate and Overexpressing an Exogenous NAD(P)+ Transhydrogenase Enzyme

Bioamber Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,850,507Yeast Cells Having Reductive TCA Pathway from Pyruvate to Succinate and Overexpressing an Exogenous NAD(P)+ Transhydrogenase Enzyme
In force
 · High confidence
Bioamber Inc.In force
High confidence
US 11,041,176Yeast Cells Having Reductive TCA Pathway From Pyruvate To Succinate And Overexpressing An Exogenous NAD(P)+ Transhydrogenase Enzyme
Lapsed Jun 22, 2025 on the fee record
Ended Jun 22, 2025 · High confidence
Cargill, IncorporatedLapsed Jun 22, 2025 on the fee recordEnded Jun 22, 2025
High confidence
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Bioamber Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited